Jacob White

jwhite@dcat.org

LATEST

The Importance of Fast Capsule Supply Lead Times

Picture this: Through what feels like a miracle, your procurement department has overcome today’s ongoing supply-chain challenges to secure a reliable supply of active pharmaceutical ingredients (APIs) for your pharmaceutical…

Sandoz Investing $400 M for New Biomanufacturing Plant
By

By
Sandoz, the generics and biosimilars business of Novartis, has signed a memorandum of understanding (MOU) to build a new biologics production plant in Lendava, Slovenia, with an investment of at…

Biogen Names New Chairman
By

By
Biogen’s Board of Directors has elected Caroline Dorsa, a former Merck & Co. executive as the company’s Chair of the Board of Directors, effective June 14, 2023, following the company’s…

Supplier News: Lonza, Catalent, Evonik, Stevanato & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Evonik, Lonza, Catalent, Stevanato, Formulated Solutions, and AtomVie.   Chemicals/Chemical API Manufacturing * AtomVie Announces Construction of Radiotherapy Mfg Facility   Biologics Manufacturing * Catalent Expands…

Global Briefs: Moderna and Sun Pharma
By

By
A roundup of news from Moderna and Sun Pharma and Highlights below.   * Moderna Sets Location for New mRNA Facility and Technology Center * Sun Pharma Completes 386-M Acquisition of Concert…

Pharma Industry Outlook and Executive Insights at DCAT Week: Online Registration Closes March 15
By

By
Online registration for DCAT Week’s education programs closes Wednesday, March 15. Be sure to register in order to get executive insights and the latest market intelligence about the bio/pharma industry’s…

ICE Pharma Has Launched its Sustainability Report

About ICE Pharma ICE Pharma is the bile acids expert, proving biliary acid derivatives as active pharmaceutical ingredients, excipients and finished dosage forms to the pharmaceutical industry. The company was  founded…

Viatris CEO Stepping Down; New CEO Named
By

By
Viatris has announced that its current CEO, Michael Goettler, is stepping down, and the company’s Board of Directors has named Scott A. Smith, recently President of BioAtla, a San Diego-based…

AstraZeneca Completes $1.8-Bn Acquisition of CinCor Pharma
By

By
AstraZeneca has completed its acquisition of CinCor Pharma, a Waltham, Massachusetts-based clinical-stage bio/pharmaceutical company, in a $1.8-billion deal ($1.3 billion upfront plus potential payments of contingent value rights). The deal…

Supplier News: Actylis, Resilience, Asahi Kasei & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Actylis, National Resilience, Asahi Kasei, Bend Bioscience, 3P Biopharmaceuticals and PackGene Biotech   Chemicals/Chemical API Manufacturing * Actylis Opens New API & Excipient Mfg…